Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

AMABELZ Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Amabelz patents expire, and what generic alternatives are available?

Amabelz is a drug marketed by Lupin Ltd and is included in one NDA.

The generic ingredient in AMABELZ is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.

Drug patent expirations by year for AMABELZ
Drug Prices for AMABELZ

See drug prices for AMABELZ

Pharmacology for AMABELZ
Synonyms for AMABELZ
19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)-, mixt. with (17beta)-estra-1,3,5(10)-triene-3,17-diol
Estra-1,3,5(10)-triene-3,17-diol (17beta)-, mixt. with 17alpha-(acetyloxy)-19-norpregn-4-en-20-yn-3-one
Estracomb TTS
Estradiol and norethindrone acetate
Estradiol mixture with norethindrone acetate
estradiol norethindrone acetate
Estradiol-norethindrone acetate mixt
Estradiol-Norethisterone acetate mixt
Estragest TTS

US Patents and Regulatory Information for AMABELZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd AMABELZ estradiol; norethindrone acetate TABLET;ORAL 203339-001 Jun 20, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd AMABELZ estradiol; norethindrone acetate TABLET;ORAL 203339-002 Jun 20, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.